Kestra Medical Technologies, Ltd.
KMTS
$24.24
-$0.75-3.00%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | |||
|---|---|---|---|---|---|
| Revenue | 82.31% | 189.91% | 189.91% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 82.31% | 189.91% | 189.91% | ||
| Cost of Revenue | 15.49% | 53.20% | 53.20% | ||
| Gross Profit | 643.98% | 623.76% | 623.76% | ||
| SG&A Expenses | 39.23% | 16.50% | 16.50% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 26.46% | 19.92% | 19.92% | ||
| Operating Income | -3.28% | 16.09% | 16.09% | ||
| Income Before Tax | -0.63% | 18.44% | 18.44% | ||
| Income Tax Expenses | 28.57% | -59.46% | -59.46% | ||
| Earnings from Continuing Operations | -0.65% | 18.47% | 18.47% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 0.51% | 19.84% | 19.84% | ||
| EBIT | -3.28% | 16.09% | 16.09% | ||
| EBITDA | -12.84% | 16.85% | 16.85% | ||
| EPS Basic | -5.98% | 13.50% | 13.50% | ||
| Normalized Basic EPS | 1.21% | 16.10% | 16.10% | ||
| EPS Diluted | -5.98% | 13.50% | 13.50% | ||
| Normalized Diluted EPS | 1.21% | 16.10% | 16.10% | ||
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | ||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||